Treatment evaluation of genetic surfactant disorder with a high-flow nasal cannula

Pediatr Int. 2022 Jan;64(1):e15004. doi: 10.1111/ped.15004.

Authors

Masao Nogami¹, Soichiro Wada¹, Shuji Sai¹, Tetsuo Onda², Kazutoshi Cho²

Affiliations

¹ Department of Pediatrics, Teine Keijinkai Hospital, Sapporo, Japan.
² Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo, Japan.

PMID: 35278247
DOI: 10.1111/ped.15004

No abstract available

Keywords: hereditary interstitial lung disease; high-flow nasal cannula; hydroxychloroquine; surfactant protein C dysfunction.

MeSH terms

Cannula*
Humans
Oxygen Inhalation Therapy
Pulmonary Surfactants* / therapeutic use
Surface-Active Agents

Substances

Pulmonary Surfactants
Surface-Active Agents